Zobrazeno 1 - 10
of 191
pro vyhledávání: '"Hiran C. Fernando"'
Autor:
Conor M. Maxwell, DO, Akash M. Bhat, BS, Samantha J. Falls, DO, Matthew Bigbee, BA, Yue Yin, PhD, Sricharan Chalikonda, MD, David L. Bartlett, MD, Hiran C. Fernando, MBBS, Casey J. Allen, MD
Publikováno v:
JTCVS Open, Vol 17, Iss , Pp 286-294 (2024)
Objective: We used a framework to assess the value implications of thoracic surgeon operative volume within an 8-hospital health system. Methods: Surgical cases for non–small cell lung cancer were assessed from March 2015 to March 2021. High-volume
Externí odkaz:
https://doaj.org/article/9a7ad5cdf74a4ddf99191ac71769cfe3
Autor:
Yayi He, Haoyue Guo, Li Diao, Yu Chen, Junjie Zhu, Hiran C. Fernando, Diego Gonzalez Rivas, Hui Qi, Chunlei Dai, Xuzhen Tang, Jun Zhu, Jiawei Dai, Kan He, Dan Chan, Yang Yang
Publikováno v:
Engineering, Vol 15, Iss , Pp 102-114 (2022)
Patient-derived tumor xenografts (PDXs) are a powerful tool for drug discovery and screening in cancer. However, current studies have led to little understanding of genotype mismatches in PDXs, leading to massive economic losses. Here, we established
Externí odkaz:
https://doaj.org/article/ff5be0d86a244933aa0d0e66330b5f06
Autor:
Bruno Hochhegger, Spencer Camargo, Gustavo Borges da Silva Teles, Rodrigo Caruso Chate, Gilberto Szarf, Marcos Duarte Guimarães, Jefferson Luiz Gross, Paula Nicole Vieira Pinto Barbosa, Rodrigo Sampaio Chiarantano, Rui Manuel Reis, Edmundo Carvalho Mauad, Mario Ghefter, Petrucio Sarmento, Raphael Pereira, José Rocha, Marcel Lima Albuquerque, André Miotto, Daniela Cristina Almeida Dias, Juliana P. Franceschini, Hiran C. Fernando, Ricardo Sales dos Santos
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
PURPOSEThis paper aims to present the results of a series of several Brazilian institutions that have been carrying out lung cancer screening (LCS).MATERIALS AND METHODSThis is a retrospective, cohort study, with follow-up of individuals of both sexe
Externí odkaz:
https://doaj.org/article/076e6c7805c243108959bc600f360747
Autor:
Xuzhen Tang, Jun Zhu, Chunlei Dai, Kan He, Yang Yang, Diego Gonzalez Rivas, Haoyue Guo, Yayi He, Hiran C. Fernando, Dan Chan, Li Diao, Junjie Zhu, Jiawei Dai, Yu Chen, Hui Qi
Publikováno v:
Engineering. 15:102-114
Patient-derived tumor xenografts (PDXs) are a powerful tool for drug discovery and screening in cancer. However, current studies have led to little understanding of genotype mismatches in PDXs, leading to massive economic losses. Here, we established
Autor:
Conor M. Maxwell, Hiran C. Fernando
Publikováno v:
Journal of Thoracic Disease. 14:3108-3110
Publikováno v:
Surgical Endoscopy. 36:7016-7024
Minimally invasive esophagectomy (MIE) for esophageal cancer has been associated with decreased pain, less blood loss, and shorter hospital stay with comparable survival to open surgery. To date, there is minimal information regarding what factors ar
Publikováno v:
Annals of Esophagus. 6:22-22
Autor:
Yaxing, Shen, Xiaosang, Chen, Junyi, Hou, Youwen, Chen, Yong, Fang, Zhanggang, Xue, Xavier Benoit, D'Journo, Robert J, Cerfolio, Hiran C, Fernando, Alfonso, Fiorelli, Alessandro, Brunelli, Jing, Cang, Lijie, Tan, Hao, Wang
Publikováno v:
Surgical endoscopy. 36(12)
The purpose of this randomized controlled trial was to determine if enhanced recovery after surgery (ERAS) would improve outcomes for three-stage minimally invasive esophagectomy (MIE).Patients with esophageal cancer undergoing MIE between March 2016
Autor:
Yao-Bin Lin, Jian-Hua Fu, Yan Huang, Yi-Huai Hu, Kong-Jia Luo, Ke-Xi Wang, Amos Éla Bella, Dong-Rong Situ, Ji-Yang Chen, Ting Lin, Xavier B D’Journo, Nuria M Novoa, Alessandro Brunelli, Hiran C Fernando, Robert J Cerfolio, Mahmoud Ismail, Yang Hong, Collaborative Group the AME Thoracic Surgery
Publikováno v:
World Journal of Gastrointestinal Oncology
Background Esophagectomy is a pivotal curative modality for localized esophageal or esophagogastric junction cancer (EC or EJC). Postoperative anastomotic leakage (AL) remains problematic. The use of fibrin sealant (FS) may improve the strength of es
Peripheral Blood Lymphocytes and Platelets Are Prognostic in Surgical pT1 Non-Small Cell Lung Cancer
Autor:
Paulo Moreira, Anita Sulibhavi, Kei Suzuki, Virginia R. Litle, Hiran C. Fernando, Benedict D.T. Daly, Sainath Asokan, Matthew I. Miller
Publikováno v:
The Annals of Thoracic Surgery. 109:337-342
Background There is a paucity of prognostic factors for patients with stage I non-small cell lung cancer (NSCLC) undergoing operations. We investigated the prognostic role of preoperative complete blood count values in patients with stage I NSCLC pat